Skip to main content

Table 5 Associations between initial AMH (ng/dl) during years 1–4 and cIMT (mm) before and after adjustment for concurrent CVD risk factors

From: Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

  Unadjusted Adjusted for age Adjusted for age and SBP Adjusted for age, total cholesterol, and HDL Adjusted for age and A1c
Models for year 1 cIMTa
 AMH 0.00009 ± 0.002 0.002 ± 0.002 0.002 ± 0.002 0.002 ± 0.002 0.002 ± 0.002
 p-value 0.95 0.11 0.10 0.22 0.13
Models for year 6 cIMTb
 AMH 0.00008 ± 0.002 0.005 ± 0.002 0.005 ± 0.002 0.004 ± 0.002 0.004 ± 0.002
 p-value 0.66 0.0087 0.008 0.019 0.014
  1. aWomen who had AMH measurement at year 1 and cIMT measurements at EDIC year 1 (n = 172)
  2. bWomen who had AMH measurement at year 1 and cIMT measurements at EDIC year 6 (n = 390)
  3. Least square means and standard errors shown